PFG Private Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,076
Closed -$52.6K 189
2025
Q1
$52.6K Hold
2,076
0.03% 93
2024
Q4
$55.1K Hold
2,076
0.03% 86
2024
Q3
$60.1K Hold
2,076
0.03% 88
2024
Q2
$58.1K Hold
2,076
0.04% 89
2024
Q1
$57.6K Sell
2,076
-1
-0% -$28 0.04% 85
2023
Q4
$59.8K Sell
2,077
-165
-7% -$4.99K 0.04% 78
2023
Q3
$74.4K Sell
2,242
-884
-28% -$31.3K 0.06% 78
2023
Q2
$115K Buy
3,126
+208
+7% +$8.1K 0.07% 87
2023
Q1
$119K Sell
2,918
-12
-0.4% -$518 0.08% 83
2022
Q4
$150K Buy
2,930
+46
+2% +$2.21K 0.09% 64
2022
Q3
$126K Buy
2,884
+60
+2% +$2.92K 0.08% 67
2022
Q2
$148K Buy
2,824
+37
+1% +$1.89K 0.08% 72
2022
Q1
$144K Hold
2,787
0.07% 72
2021
Q4
$165K Buy
2,787
+105
+4% +$5.2K 0.09% 63
2021
Q3
$115K Buy
+2,682
New +$119K 0.07% 63

Other funds holding PFE

PFG Private Wealth Management's PFE Position: Q2 2025 in Review

PFG Private Wealth Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 2,076 shares — an estimated $52.6K sold.

PFG Private Wealth Management first reported a position in PFE in Q3 2021 and held it in 15 quarters. The position peaked at $165K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • PFG Private Wealth Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • PFG Private Wealth Management sold 2,076 Pfizer shares in Q2 2025, an estimated $52.6K.
  • PFG Private Wealth Management first reported a position in Pfizer in Q3 2021 and held it in 15 quarters.
  • PFG Private Wealth Management's Pfizer position peaked at $165K in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.